Laurus Labs
₹2,059
- Market Cap
- ₹1,11,141Cr.
- P/E Ratio
- 101.7
- P/B Ratio
- 20.97
- EPS (TTM)
- ₹20.25
- Div Yield
- 0.1%
- ROCE
- 17.8%
- ROE
- 18.3%
52W Low: ₹87052W High: ₹2,086
Themes:💊 Pharma & CDMO
Appears in 3 screens
Descriptive screens built from published data — not investment advice.
At a glance
- Sales have grown 4.0% a year over three years.
- Debt is 0.48× its shareholders’ equity.
From reported financials and exchange prices. Descriptive only, not advice.
Laurus_Labs — Price
Interval
Style
Failed: 503
Evenstocks Score
Middle third
Overall
Valuation
Quality
Fundamental
Growth
Investment Checklist
Quick assessment based on key parametersPerformance
N/ATrailing return unavailableValuation
P/E 101.7P/E: 101.7 | P/B: 20.97Growth
ModestSales CAGR — 3Y: 4% · 1Y: 23%Profitability
ModerateROCE: 17.8% | ROE: 18.3%Key Metrics
Valuation
PEG Ratio 25.43
Price / Sales 15.29x
Price / FCF 198.5x
Book Value ₹98.2
Margins & returns
Operating Margin 28%
Net Margin 15.0%
Return on Assets 10.4%